$100 invested in abbvie 10 years ago would be worth this much today. abbvie (nyse:) has outperformed the market over the past 10 years by 2.04% on an annualized basis producing an average annual return of 12.13%. currently abbvie has a market capitalizati

abbvie unusual options activity. someone with a lot of money to spend has taken a bearish stance on ). and retail traders should know. we noticed this today when the big position showed up on publicly available options history that we track here at benz

coherus biosciences to launch humira biosimilar at 85% discount. coherus biosciences inc said on thursday it plans to launch a biosimilar of abbvie incs humira in july at a list price of $995 per carton representing a discount of about 85% from

why abbvie and amgen are moving lower today. what happened shares of the immunology juggernaut abbvie (nyse: abbv) were down by 4% on sky-high volume as of 11 a.m. et thursday. thats equivalent to a $7 billion drop in market capitalization.

abbvie says upadacitinib 30 mg meets primary goals in sle patients in mid-stage study. (rttnews) - abbvie inc. (abbv) a clinical-stage pharmaceutical company wednesday announced the results of its phase 2 sleek study evaluating upadacitinib (ri

2 dividend kings on sale that are yielding more than 4%. dividend kings have excellent track records for dividend growth and are often seen as some of the safest income investments to own. two dividend growth stocks that may look tempting and th

oversold conditions for abbvie. legendary investor warren buffett advises to be fearful when others are greedy and be greedy when others are fearful. one way we can try to measure the level of fear in a given stock is through a technical an

abbvie (abbv) gets fda nod for lymphoma drug epcoritamab. abbvie abbv and partner genmab gmab announced that the fda has granted accelerated approval to their t-cell engaging bispecific antibod

abbvie genmab granted fda nod for lymphoma therapy.

us fda approves genmab-abbvies blood cancer therapy. the United States food and drug administration has approved abbvie inc and danish drugmaker genmabs experimental blood cancer therapy for adult patients who have received at least two prior li

abbvies (abbv) rinvoq gets fda nod to treat crohns disease. abbvieabbv announced the fda approval of its immunology drug rinvoq (upadacitinib) a once-daily pill for the treatment of adults with moderately to severely active crohns dise

fda approves abbvies rinvoq as once-daily pill for crohns disease in adults. (rttnews) - the United States food and drug administration approved abbvies (abbv) rinvoq or upadacitinib for the treatment of adults with moderately to severely active

allergan aesthetics says fda approves skinvive by juvederm. (rttnews) - allergan aesthetics an abbvie company (abbv) announced monday the United States fda approval of skinvive by juvederm to improve skin smoothness of the cheeks in adults over

this is what whales are betting on abbvie. a whale with a lot of money to spend has taken a noticeably ish stance on looking at options history for abbvie (nyse:) we detected 14 strange trades. if we consider the specifics of each trade it is accurate

unusual put option trade in abbvie (abbv) worth $4742.50k. on may 10 2023 at 15:19:36 et an unusually large $4742.50k block of put contracts in abbvie (abbv) was bought with a strike price of $160.00 / share expiring in 9 da

unusual put option trade in abbvie (abbv) worth $11130.00k. on may 10 2023 at 15:19:36 et an unusually large $11130.00k block of put contracts in abbvie (abbv) was bought with a strike price of $165.00 / share expiring in 37

abbvie: a rise in the incidence of ibd could boost profits.

abbvie: a rise in the incidence of ibs could boost profits.

abbvies rinvoq gets approval in canada for expanded use in axial spondyloarthritis.

looking at abbvies recent unusual options activity. a whale with a lot of money to spend has taken a noticeably bearish stance on looking at options history for abbvie (nyse:) we detected 11 strange trades. if we consider the specifics of each trade it

heres how much $1000 invested in abbvie 10 years ago would be worth today. abbvie (nyse:) has outperformed the market over the past 10 years by 3.1% on an annualized basis producing an average annual return of 12.85%. currently abbvie has a market capital

2 things about abbvie that investors are ignoring. investors were ready for declines in abbvies (nyse: abbv) blockbuster immunology drug humira. the product now is facing competition in the United States so seeing a 26% drop in humiras United St

abbvie sells off i am buying.

unusual put option trade in abbvie (abbv) worth $1585.00k. on may 1 2023 at 11:32:44 et an unusually large $1585.00k block of put contracts in abbvie (abbv) was sold with a strike price of $150.00 / share expiring in 627 day

notable monday option activity: abbv orcl mtch. among the underlying components of the s&.p 500 index we saw noteworthy options trading volume today in abbvie inc (symbol: abbv) where a total of 27571 contracts have traded so far represen

guggenheim maintains abbvie (abbv) buy recommendation. fintel reports that on april 28 2023 guggenheim maintained coverage of abbvie (nyse:abbv) with a buy recommendation.

morgan stanley maintains abbvie (abbv) overweight recommendation. fintel reports that on april 28 2023 morgan stanley maintained coverage of abbvie (nyse:abbv) with a overweight recommendation.

wells fargo maintains abbvie (abbv) overweight recommendation. fintel reports that on april 28 2023 wells fargo maintained coverage of abbvie (nyse:abbv) with a overweight recommendation.

why abbvie stock is crashing today. what happened shares of the pharmaceutical giant abbvie (nyse: abbv) fell by as much as 9% in early morning trading thursday. the drugmakers shares have recovered since hitting this intra-day low but they wer

thursday sector laggards: healthcare energy. the worst performing sector as of midday thursday is the healthcare sector not showing much of a gain. within that group align technology inc (symbol: algn) and abbvie inc (symbol: abbv) are two